AtriCure officer proposes $546K share sale
His three reported September sales involved 4,519, 3,657 and 7,763 shares, providing transaction history alongside the proposed sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AtriCure, Inc. officer Salvatore Privitera reported a proposed sale of 8,404 common shares, with an aggregate market value of $546,260.00 and an approximate sale date of November 4, 2026. The shares are identified as restricted stock acquired from the issuer on July 24, 2021. The notice also lists sales by Privitera of 4,519 shares on September 23, 2026, 3,657 shares on September 8, 2026, and 7,763 shares on September 2, 2026.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.